Literature DB >> 20480894

Quantification of glycyrrhizin in Glycyrrhiza glabra extract by validated HPTLC densitometry.

Arunava Gantait1, Subrata Pandit, Neelesh K Nema, Pulok K Mukjerjee.   

Abstract

Glycyrrhiza glabra Linn (Family-Fabaceae) is active as an anti-allergic, anti-inflammatory, spasmolytic, mild laxative, antistress, antidepressive, antiulcer, liver protective, estrogenic, emmenagogue, and antidiabetic substance, and is widely used in the Indian system of medicine. The major bioactive constituent is glycyrrhizin. A simple HPTLC method has been developed to control the quality of raw as well as finished glycyrrhiza using glycyrrhizin as the bioactive marker. The solvent system was optimized to chloroform-methanol-water (65 + 36 + 7.5, v/v/v). Extract and standard were dissolved in 70% methanol and applied on a precoated TLC plate. After development, the plate was scanned at 254 nm to create a chromatogram, then the quantity of glycyrrhizin was determined in the extract. The method was validated in terms of specificity, linearity, precision, LOD, and LOQ. Linearity range was found to be 0.96-4.80 microg per spot. The linearity relationship was described by the equation: Y = 612.706 + 1.091X (with r = 0.99904 and SD = 2.52%), where Y is the area under curve and X is the amount of glycyrrhizin (ng). The amount of glycyrrhizin found in the extract was 9.1%. Thus, the method provides a rapid and cost-effective quality measure for Glycyrrhiza glabra hydroalcoholic extract.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480894

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  3 in total

1.  QUANTIFICATION OF GLYCYRRHIZIN BIOMARKER IN GLYCYRRHIZA GLABRA RHIZOME AND BABY HERBAL FORMULATIONS BY VALIDATED RP-HPTLC METHODS.

Authors:  Prawez Alam; Ahmed I Foudah; Hala H Zaatout; Kamal Y T; Maged S Abdel-Kader
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

2.  Inhibitory Effects of Glycyrrhiza glabra and Its Major Constituent Glycyrrhizin on Inflammation-Associated Corneal Neovascularization.

Authors:  Syed Luqman Shah; Fazli Wahid; Noorullah Khan; Umar Farooq; Abdul Jabbar Shah; Shah Tareen; Fiaz Ahmad; Taous Khan
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-23       Impact factor: 2.629

Review 3.  Interferon-inducer antivirals: Potential candidates to combat COVID-19.

Authors:  Ashkan Bagheri; Seyed Mohammad Iman Moezzi; Pouria Mosaddeghi; Sadra Nadimi Parashkouhi; Seyed Mostafa Fazel Hoseini; Fatemeh Badakhshan; Manica Negahdaripour
Journal:  Int Immunopharmacol       Date:  2020-12-01       Impact factor: 5.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.